Evidence map›Paper›PMID 27354544›Full record

ArticlePhysiological reports2016

Pericardial patch venoplasty heals via attraction of venous progenitor cells.

Hualong Bai, Mo Wang, Trenton R Foster, Haidi Hu, Hao He, Takuya Hashimoto, Jesse J Hanisch, Jeans M Santana, Ying Xing, Alan Dardik

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Patch Angioplasty in the Rat Aorta or Inferior Vena Cava.Journal of visualized experiments : JoVE · 2017
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Hualong BaiThe Vascular Biology and Therapeutics Program and the Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Basic Medical College of Zhengzhou University, Henan, China Department of Vascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan, China.
Mo WangThe Vascular Biology and Therapeutics Program and the Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Department of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.
Trenton R FosterThe Vascular Biology and Therapeutics Program and the Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.
Haidi HuThe Vascular Biology and Therapeutics Program and the Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Department of Surgery, VA Connecticut Healthcare System, West Haven, Connecticut.
Hao HeThe Vascular Biology and Therapeutics Program and the Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Department of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.
Takuya HashimotoThe Vascular Biology and Therapeutics Program and the Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Department of Surgery, VA Connecticut Healthcare System, West Haven, Connecticut.
Jesse J HanischThe Vascular Biology and Therapeutics Program and the Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.
Jeans M SantanaThe Vascular Biology and Therapeutics Program and the Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.
Ying XingBasic Medical College of Zhengzhou University, Henan, China.
Alan DardikThe Vascular Biology and Therapeutics Program and the Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Department of Surgery, VA Connecticut Healthcare System, West Haven, Connecticut alan.dardik@yale.edu.
Yale University · USZhengzhou University · CNCentral South University · CNSecond Xiangya Hospital of Central South University · CNVA Connecticut Healthcare System · US

Funding

Molecular Regulation of Vein Graft AdapationR01HL095498 · NHLBI · YALE UNIVERSITY · PI DARDIK, ALAN · 2009 to 2013
$2.4M
Molecular regulation of vein graft adaptationR56HL095498 · NHLBI · YALE UNIVERSITY · PI DARDIK, ALAN · 2014 to 2014
$416k
Molecular regulation of fistula adaptation for dialysis accessI01BX002336 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI DARDIK, ALAN · 2014 to 2017
–
BLRD VA I01 BX002336NHLBI NIH HHS R01 HL095498NHLBI NIH HHS R01-HL-095498NHLBI NIH HHS R56 HL095498NHLBI NIH HHS R56-HL095498
6 · The paper itself

Abstract

Pericardial patches are commonly used during cardiovascular surgery to close blood vessels. In arteries, patches accumulate arterial progenitor cells; we hypothesized that venous patches would accumulate venous progenitor cells, in the absence of arterial pressure. We developed a novel rat inferior vena cava (IVC) venotomy model and repaired it with a pericardial patch. Cells infiltrated the patch to form a thick neointima by day 7; some cells were CD34(+)/VEGFR2(+) and CD31(+)/Eph-B4(+) consistent with development of venous identity in the healing patch. Compared to arterial patches, the venous patches had increased neointimal thickness at day 7 without any pseudoaneurysms. Addition of an arteriovenous fistula (AVF) to increase blood flow on the patch resulted in reduced patch neointimal thickness and proliferation, but neointimal thickness was not reversible with AVF ligation. These results show that rat patch venoplasty is a novel model of aggressive venous neointimal hyperplasia.

Indexed as

RegenerationAdult Stem CellsAngioplastyAnimalsAntigens, CD34MalePericardiumPlatelet Endothelial Cell Adhesion Molecule-1RatsRats, WistarReceptor, EphB4Tunica IntimaVascular Closure DevicesVascular Endothelial Growth Factor Receptor-2Vena Cava, InferiorAntigens, CD34Platelet Endothelial Cell Adhesion Molecule-1Receptor, EphB4Vascular Endothelial Growth Factor Receptor-2Aortocaval fistulaarterioplastyarteriovenous fistulaAVF ligationEph‐B4pericardial patchespseudoaneurysmvenoplastyvenous neointimal hyperplasia

Identifiers

PMID27354544
PMCPMC4923240
OpenAlexW2463955220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.